Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fenspiride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 465Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Withdrawal of marketing authorisations for fenspiride medicines
    Withdrawal of marketing authorisations for fenspiride medicines

    29 May 2019

    // EMA

    https://www.ema.europa.eu/en/news/withdrawal-marketing-authorisations-fenspiride-medicines-0

    EMA
    29 May 2019
    Share Share
    EMA’s PRAC Calls for Withdrawal of Fenspiride CoughMedicines,Restrict on Xeljanz
    EMA’s PRAC Calls for Withdrawal of Fenspiride CoughMedicines,Restrict on Xeljanz

    23 May 2019

    // Nick Paul Taylor RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/5/eu-regulatory-roundup-emas-prac-calls-for-withdr

    Nick Paul Taylor RAPS
    23 May 2019
    Share Share
    Withdrawal of marketing authorisations for fenspiride medicines
    Withdrawal of marketing authorisations for fenspiride medicines

    18 May 2019

    // EMA

    https://www.ema.europa.eu/en/news/withdrawal-marketing-authorisations-fenspiride-medicines

    EMA
    18 May 2019
    Share Share
    EMA suspends fenspiride medicines due to heart rhythm risks
    EMA suspends fenspiride medicines due to heart rhythm risks

    19 Feb 2019

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/ema_suspends_fenspiride_medicines_due_to_heart_rhythm_risks_1278637

    Anna Smith PHARMA TIMES
    19 Feb 2019
    Share Share
    Suspension of fenspiride medicines due to risk of heart rhythm problems
    Suspension of fenspiride medicines due to risk of heart rhythm problems

    15 Feb 2019

    // EMA

    https://www.ema.europa.eu/en/news/suspension-fenspiride-medicines-due-potential-risk-heart-rhythm-problems

    EMA
    15 Feb 2019
    Share Share
    Meeting highlights from PV Risk Assessment Committee 11-14 Feb 2019
    Meeting highlights from PV Risk Assessment Committee 11-14 Feb 2019

    15 Feb 2019

    // EMA

    https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-11-14-february-2019

    EMA
    15 Feb 2019
    Share Share